Synta Pharmaceuticals Investigative Site — Philadelphia, Pennsylvania

Synta Pharmaceuticals Investigative Site is a clinical research site located in Philadelphia, Pennsylvania, United States 19111-2497.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Synta Pharmaceuticals Investigative Site has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer.

Sponsors: Synta Pharmaceuticals Corp..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synta Pharmaceuticals Investigative Site?

Synta Pharmaceuticals Investigative Site has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synta Pharmaceuticals Investigative Site conducted?

Synta Pharmaceuticals Investigative Site has 1 clinical trials on record. Their work covers Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer.

Is Synta Pharmaceuticals Investigative Site accredited by Crixeo Health?

Synta Pharmaceuticals Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synta Pharmaceuticals Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.